EBRO 2017

Priority

Patients

Oncologists

Incontinence 29 (47%)

24 (41%)

6%

Local control

21 (34%)

20 (34%)

0%

Survival

7 (11%)

12 (20%)

9%

Sexual dysfunction

5 (8%)

3 (5%)

3%

Pieterse AH, et al. Br J Cancer. 2007;97(6):717-24